RecallDepth
Class III Ongoing

Trandolapril and Verapamil Hydrochloride Extended-Release Tablets 2 mg / 180 mg, 100-count Bottle, Rx only, Manufactured by: Glenmark Pharmaceuticals Ltd. Colvale -Bardez, Goa 403513, India, Manufactured for Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, NDC 68462-295-01

Company
Glenmark Pharmaceuticals Inc., Usa
Recall Initiated
August 14, 2023
Posted
August 30, 2023
Recall Number
D-1095-2023
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
1,200 bottles
Firm Location
Mahwah, NJ, United States

Reason for Recall

Subpotent: Out of Specification for Assay Test at the 3-month time point.

Distribution

nationwide in the U.S.

Lot / Code Info

Batch # 19224744

More recalls by Glenmark Pharmaceuticals Inc., Usa

View all recalls by this company →

Other recent Class III Drug recalls